Medical News

RSS

DOD awards $2.24 million grant to study keratin gel in peripheral nerve regeneration

Orthopaedic researchers at Wake Forest University Baptist Medical Center (WFUBMC) have been awarded a $2.24 million four-year grant from the U. S. Department of Defense (DOD) to study the use of keratin gel in the regeneration of damaged peripheral nerves, those in the hands, arms and feet.

2 Dec 2010

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.

From Quest Diagnostics 2 Dec 2010

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).

2 Dec 2010

Improved support may reduce health care cost in children with diabetes

Managing diabetes in a child requires a careful balance of insulin, diet, and exercise. Buying essential medical supplies, such as needles and testing strips, adds a financial burden to families. According to a new study soon to be published in The Journal of Pediatrics, the resulting food insecurity that arises from the financial burden of diabetes management increases a child's risk of being hospitalized due to complications from diabetes.

2 Dec 2010

Regular, low-cost preventive medication can protect people with HIV from TB

Children and adults living with HIV can be protected from one of their deadliest threats - tuberculosis (TB) - with a regular, low-cost preventive medication according to new guidelines launched today by the WHO. Of the nearly two million AIDS-related deaths each year, a quarter of them are associated with TB.

2 Dec 2010

Graphene: A new genome sequencing technique

Genome sequencing will have a profound effect on our understanding of genetic biology and could usher in a day when doctor and patient are able to review individual genome sequences to fully personalise medical treatment.

2 Dec 2010

IPC acquires Senior Care of Colorado

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Senior Care of Colorado, PC (SCOC) headquartered in Aurora, Colorado. SCOC provides geriatric care at more than 200 facilities in the Denver metro area. SCOC has an annualized volume of more than 200,000 patient encounters. This acquisition represents an expansion of operations for IPC in Colorado, where the company has provided acute care hospitalist services since 2003.

2 Dec 2010

Inserting plant's clock gene could replace circardian clock defect in humans

A gene that controls part of the 'tick tock' in a plant's circadian clock has been identified by UC Davis researchers. And not only is the plant gene very similar to one in humans, but the human gene can work in plant cells and vice versa.

2 Dec 2010

Stemline to feature SL-401 clinical efficacy at ASH Annual Meeting

Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.

2 Dec 2010

New radiation-free device to detect breast cancer

A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.

2 Dec 2010

Vision problems in stroke patients can impact rehabilitation

Visual problems can affect up to two thirds of stroke patients, but can sometimes go undetected if patients do not recognise them as an after-effect of the condition or if they are unable to communicate the problem to their medical team or families.

2 Dec 2010

Philips launches Juno DRF and DigitalDiagnost - ER Wireless X-ray solutions at 96th RSNA

Royal Philips Electronics today introduced the Juno DRF and the DigitalDiagnost - ER Wireless systems, two versatile diagnostic X-ray solutions that represent the next step in patient care. Featured at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, these innovative systems uphold Philips' commitment to integrating technologies in a smart way to help enhance patient outcomes and increase value for healthcare systems.

From Philips Healthcare 2 Dec 2010

Exposure to BPA during perinatal development impairs reproductive capacity of female offspring

Exposure to a ubiquitous environmental chemical during pregnancy may impair reproductive capacity of female offspring, according to a study published online in advance of print on December 2 in Environmental Health Perspectives. Fertility decreased over time in female mice that had been exposed during fetal and neonatal (perinatal) development to doses of bisphenol-A (BPA) that were lower than or equal to human environmental exposure levels.

2 Dec 2010

Biomagnetics identifies second biomarker for tuberculosis assay

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced the identification of a second biomarker for development of a tuberculosis assay.

2 Dec 2010

Cellectis signs agreement with Harvard Apparatus for electroporation-based instruments

Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.

2 Dec 2010

CSL Behring launches next generation HeliTrax System for Apple's devices

CSL Behring announced today the availability of the next generation HeliTrax System as part of a specially designed software platform for Apple's iPhone, iPod touch, or iPad devices. This enhanced system is designed to improve therapy management for people with hemophilia A who use CSL Behring's recombinant factor VIII (rFVIII).

2 Dec 2010

Supreme Court considers overcrowding's effect on Cal. prison health care

The U.S. Supreme Court is considering an order requiring California prisons to release 40,000 inmates because overcrowding has limited prisoners' access to health care.

2 Dec 2010

FDA advisory committee votes against Avodart sNDA for prostate cancer risk reduction

GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).

2 Dec 2010

Current Opinion in Lipidology journal publishes data on VB-201 for immune-mediated disorders

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of a new concept in the Current Opinion in Lipidology evaluating oxidized phospholipid analogs as potential treatments for chronic inflammatory diseases.

2 Dec 2010

CytRx commences tamibarotene Phase 2b clinical trial in NSCLC

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it is initiating a multicenter Phase 2b clinical trial with its oncology drug candidate tamibarotene in combination with chemotherapeutical agents for the treatment of patients with advanced non-small-cell lung cancer (NSCLC).

2 Dec 2010

Medical News

DOD awards $2.24 million grant to study keratin gel in peripheral nerve regeneration

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Improved support may reduce health care cost in children with diabetes

Regular, low-cost preventive medication can protect people with HIV from TB

Graphene: A new genome sequencing technique

IPC acquires Senior Care of Colorado

Inserting plant's clock gene could replace circardian clock defect in humans

Stemline to feature SL-401 clinical efficacy at ASH Annual Meeting

New radiation-free device to detect breast cancer

Vision problems in stroke patients can impact rehabilitation

Philips launches Juno DRF and DigitalDiagnost - ER Wireless X-ray solutions at 96th RSNA

Exposure to BPA during perinatal development impairs reproductive capacity of female offspring

Biomagnetics identifies second biomarker for tuberculosis assay

Cellectis signs agreement with Harvard Apparatus for electroporation-based instruments

CSL Behring launches next generation HeliTrax System for Apple's devices

Supreme Court considers overcrowding's effect on Cal. prison health care

FDA advisory committee votes against Avodart sNDA for prostate cancer risk reduction

Current Opinion in Lipidology journal publishes data on VB-201 for immune-mediated disorders

CytRx commences tamibarotene Phase 2b clinical trial in NSCLC

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News